FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, EAR, HYZN and SAVA Biotech Investing
Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia Biotech Investing
Naturally Splendid Container of NATERA Plant Based Foods Arrives With Additional Plant-Based Offerings Biotech Investing
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, HNST, HYZN, SAM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Biotech Investing
U.S. Food and Drug Administration Approves Expanded Indication of Gilead's Biktarvy® for Treatment of HIV-1 in Pediatric Populations Biotech Investing
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx, into Brazil, Mexico, and Canada Biotech Investing
APPH, BMY, EAR, HYZN SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set Biotech Investing
AbbVie Receives CHMP Positive Opinion for Risankizumab for the Treatment of Adults with Active Psoriatic Arthritis in the European Union Biotech Investing
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis Biotech Investing
